217 related articles for article (PubMed ID: 7338157)
1. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
Fenoglio CM; Crum CP; Pascal RR; Richart RM
Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
Puri S; Mesa-Tejada R; Husami N; Bennett S; Richart RM; Fenogolio CM
Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
[No Abstract] [Full Text] [Related]
3. [Plasma fibrinogen in female patients with genital cancer and its early stage].
Lober R; Krantz S; Lober M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):71-81. PubMed ID: 2581873
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
5. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
Anger H; Gleissenberger U
Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K; Breborowicz J
Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
[No Abstract] [Full Text] [Related]
7. [Fibrinogen degradation products in gynecologic neoplasms].
Tatra G; Breitenecker G; Karsai I
Fortschr Med; 1976 May; 94(13):752-4. PubMed ID: 955534
[TBL] [Abstract][Full Text] [Related]
8. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
9. [A critical study on the differentiation of the acceleration of the erythrocyte sedimentation rate due to tumorous and inflammatory processes in diseases of the female genitalia].
Schander K
Z Geburtshilfe Gynakol; 1969; 170(1):73-7. PubMed ID: 5794762
[No Abstract] [Full Text] [Related]
10. Serum copper alterations in genital cancer.
O'Leary JA; Feldman M
Surg Forum; 1970; 21():411-2. PubMed ID: 5514783
[No Abstract] [Full Text] [Related]
11. Tumor and serum CEA content in gynecologic neoplasms.
Kula J; Richter R; Gawlikowski W; Harłozińska A
Neoplasma; 1984; 31(1):89-93. PubMed ID: 6322027
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer.
Khoo SK; Daunter B; Mackay E
Int J Gynaecol Obstet; 1979; 16(5):388-93. PubMed ID: 86469
[TBL] [Abstract][Full Text] [Related]
13. [CEA monitoring of gynecologic tumor patients using a simplified CEA-radioimmunoassay].
Hörst M; Wiest W
Fortschr Med; 1982 Mar; 100(11):482-3. PubMed ID: 7076078
[No Abstract] [Full Text] [Related]
14. Biochemical markers in gynaecological cancer.
Farrell RJ
Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
[No Abstract] [Full Text] [Related]
15. Carcinoembryoinc antigen in cervical and vulvar cancer patients. Serum levels and disease progress.
DiSaia PJ; Morrow CP; Haverback BJ; Dyce BJ
Obstet Gynecol; 1976 Jan; 47(1):95-9. PubMed ID: 1246404
[TBL] [Abstract][Full Text] [Related]
16. Multiple biochemical markers in patients with gynecologic malignancies.
Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
[TBL] [Abstract][Full Text] [Related]
17. [A case of immunohistochemically carcinoembryonic antigen producing cervical cancer--the evaluation of plasma CEA levels in 201 patients with uterine cancer].
Yokoyama T; Kaneko H; Kawamura S; Tanaka M; Chiba T; Hiura M; Moriwaki S
Gan No Rinsho; 1987 Jul; 33(8):975-80. PubMed ID: 3613119
[TBL] [Abstract][Full Text] [Related]
18. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
19. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
20. [CEA and the clinical course in advanced carcinoma of the uterine cervix (author's transl)].
Braun P; Leyendecker G
Geburtshilfe Frauenheilkd; 1982 Jun; 42(6):462-7. PubMed ID: 6921128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
